Drugs / plasma rich platelet PRP
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03164122 | May 2017 → Jun 2018 | osteoarthritis | Assistance Publique Hopitaux De Marseille | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | plasma rich platelet PRP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03164122 ↗ |
| Known as | platelets-rich plasma | “Microfat (MF) and platelets-rich plasma (PRP) mixture, rich in growth factors and ADSC could be a minimally invasive injectable option in the treatment of wrist osteoarthritis.” PMID 36233654 ↗ Sep 2022 |
| Modality | Other / unclassified | “autologous biological medicine” NCT03164122 ↗ |
| Route | Other | “intra-articular injection” NCT03164122 ↗ |